Skip to content 
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified. more
| Time Frame | HELX | S&P500 |
|---|---|---|
| 1-Week Return | -2.27% | 0.01% |
| 1-Month Return | 14.91% | 3.54% |
| 3-Month Return | 22.86% | 10.58% |
| 6-Month Return | 7.17% | 8.03% |
| 1-Year Return | 40.97% | 20.06% |
| 3-Year Return | 33.85% | 70.98% |
| 5-Year Return | -20.95% | 71.89% |
| 10-Year Return | 67.69% | 252.66% |
| Stock name | Ticker | Weight |
|---|---|---|
 GUARDANT HEALTH INC | GH | 9.64% |
 NATERA INC | NTRA | 7.51% |
 KRYSTAL BIOTECH INC | KRYS | 6.13% |
 LIGAND PHARMACEUTICALS | LGND | 4.57% |
 BRIDGEBIO PHARMA INC | BBIO | 4.11% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 3.93% |
 UNITED THERAPEUTICS CORP | UTHR | 3.47% |
 ELI LILLY & CO | LLY | 2.91% |
 VERTEX PHARMACEUTICALS IN | VRTX | 2.66% |
 INSMED INC | INSM | 2.62% |
 TRAVERE THERAPEUTICS INC | TVTX | 2.59% |
 TWIST BIOSCIENCE CORP | TWST | 2.52% |
 ASTRAZENECA PLC | AZN.L | 2.47% |
 CORTEVA INC | CTVA | 2.16% |
 SAMSUNG BIOLOGICS CO LTD | 207940.KS | 2.14% |
 MEDPACE HOLDINGS INC | MEDP | 2.1% |
 TEMPUS AI INC-CL A | TEM | 2.01% |
 ALNYLAM PHARMACEUTICALS I | ALNY | 1.97% |
 NEUROCRINE BIOSCIENCES IN | NBIX | 1.92% |
 REGENERON PHARMACEUTICALS | REGN | 1.87% |
 VERACYTE INC | VCYT | 1.61% |
 ARGENX SE | ARGX.BR | 1.56% |
 PTC THERAPEUTICS INC | PTCT | 1.56% |
 IONIS PHARMACEUTICALS INC | IONS | 1.5% |
 BIONTECH SE-ADR | BNTX | 1.34% |
 STOKE THERAPEUTICS INC | STOK | 1.29% |
 CHARLES RIVER LABORATORIE | CRL | 1.26% |
 CASH | CASH | 1.25% |
 GRAIL INC | GRAL | 1.17% |
 REPLIGEN CORP | RGEN | 1% |
 ANAPTYSBIO INC | ANAB | 0.99% |
 CRISPR THERAPEUTICS AG | CRSP | 0.98% |
 CADENCE DESIGN SYS INC | CDNS | 0.97% |
 BEAM THERAPEUTICS INC | BEAM | 0.94% |
 SARTORIUS AG-VORZUG | SRT3.DE | 0.84% |
 PRAXIS PRECISION MEDICINE | PRAX | 0.83% |
 CAREDX INC | CDNA | 0.81% |
 AXSOME THERAPEUTICS INC | AXSM | 0.81% |
 IQVIA HOLDINGS INC | IQV | 0.78% |
 JAZZ PHARMACEUTICALS PLC | JAZZ | 0.78% |
 THERMO FISHER SCIENTIFIC | TMO | 0.77% |
 CATALYST PHARMACEUTICALS | CPRX | 0.75% |
 HINGE HEALTH INC-A | HNGE | 0.73% |
 ULTRAGENYX PHARMACEUTICAL | RARE | 0.62% |
 DANAHER CORP | DHR | 0.57% |
 AGILENT TECHNOLOGIES INC | A | 0.57% |
 QIAGEN N.V. | QIA.DE | 0.5% |
 ARCUTIS BIOTHERAPEUTICS I | ARQT | 0.44% |
 RHYTHM PHARMACEUTICALS IN | RYTM | 0.42% |
 KINIKSA PHARMACEUTICALS I | KNSA | 0.34% |
 SAMSUNG EPISHOLDINGS CO L | 0126Z0.KS | 0.32% |
 FIRST TRACKS BIOTHERAPEUT | TRAX | 0.31% |
 NEUROGENE INC | NGNE | 0.29% |
 TG THERAPEUTICS INC | TGTX | 0.26% |
 TARSUS PHARMACEUTICALS IN | TARS | 0.25% |
 BIO-RAD LABORATORIES-A | BIO | 0.25% |
 LIQUIDIA CORP | LQDA | 0.25% |
 BRISTOL-MYERS SQUIBB CO | BMY | 0.24% |
 BEONE MEDICINES LTD-ADR | ONC | 0.24% |
 GENEDX HOLDINGS CORP | WGS | 0.14% |
 WAVE LIFE SCIENCES LTD | WVE | 0.11% |
 RECURSION PHARMACEUTICALS | RXRX | 0.07% |
 OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
 OMNIAB INC - 15.00 EARNOU | 2200964 | 0% |
 Net Current Assets | Net.Current.Assets | 0% |
| Sector | Weight |
|---|---|
|
Health care | 96.57% |
|
Materials | 2.28% |
|
Information Technology | 1.14% |
Franklin Genomic Advancements ETF (HELX) share price today is $40.1811.
Yes, Indians can buy shares of Franklin Genomic Advancements ETF (HELX) on Vested. To buy HELX from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Franklin Genomic Advancements ETF (HELX) on Vested. You can start investing in Franklin Genomic Advancements ETF (HELX) with a minimum investment of $1.
The 52-week high price of Franklin Genomic Advancements ETF (HELX) is $41.3. The 52-week low price of Franklin Genomic Advancements ETF (HELX) is $26.89.
The stock symbol (or ticker) of Franklin Genomic Advancements ETF is HELX.
Yes, you can setup SIP in Franklin Genomic Advancements ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of HELX on the Vested app.
The expense ratio of Franklin Genomic Advancements ETF (HELX) is 0.5%.
Link copied 
